This study explores the role of oxidative stress in the pathogenesis and treatment of inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis. It highlights how reactive oxygen species (ROS) contribute to intestinal inflammation, mucosal damage, and increased risk of colitis-associated colorectal cancer. The article reviews antioxidant therapies, including
